EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc (EKDHF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ekdhf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for EKF Diagnostics Holdings plc (EKDHF) measures how much investors pay for each dollar of the company's trailing earnings. EKDHF's current PE ratio of 52.61x is calculated by dividing its stock price of $0.39 by its TTM earnings per share of $0.00. +58.2% elevated vs 5Y avg 33.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%23.6x
MedianQ3 · 75%53.8x
Max
At 52.61x, EKDHF's current P/E is higher than in 91% of its annual fiscal year readings over the past 11 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
EKF Diagnostics Holdings plcYou EKDHF | $168M | 52.61x | — | $0.00 |
 Adocia S.A. ADOCY | $170M | N/A | — | -$0.81 |
 ACS Global, Inc. AMCY | $171M | N/A | — | — |
 Anteris Technologies Ltd AMEUF | $120M | N/A | — | -$6.09 |
 AnGes, Inc. AMGXF | $143M | N/A | — | -$14.45 |
 Broncus Holding Corporation BRNHF | $162M | N/A | — | -$0.03 |
 Cell MedX Corp. CMXC | $126M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 53.81x | $0.00 | +160.3% | |
2024-12-31 FY2024 | 20.67x | $0.01 | -56.5% | |
2023-12-31 FY2023 | 47.53x | $0.01 | — | |
2022-12-31 FY2022 | — | $-0.02 | — | |
2021-12-31 FY2021 | 23.64x | $0.03 | +14.8% | |
2020-12-31 FY2020 | 20.60x | $0.02 | -43.7% | |
2019-12-31 FY2019 | 36.62x | $0.01 | +150.1% | |
2018-12-31 FY2018 | 14.64x | $0.02 | -66.7% | |
2017-12-31 FY2017 | 43.91x | $0.01 | — | |
2016-12-31 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for EKF Diagnostics Holdings plc (EKDHF) measures how much investors pay for each dollar of the company's trailing earnings. EKDHF's current PE ratio of 52.61x is calculated by dividing its stock price of $0.39 by its TTM earnings per share of $0.00.
Frequently asked questions
EKDHF pe ratio · 6 questionsEKDHF's current PE ratio is 52.61x as of 2026-06-08, based on a stock price of $0.39 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via EKDHF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · EKF Diagnostics Holdings plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08